Patents by Inventor Shylaja Mallaiah Dharmesh

Shylaja Mallaiah Dharmesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8158608
    Abstract: Ulcer is a serious oxidative stress induced disease with complex pathologic events including upregulation of H+K+ ATPase of parietal cell (PC) membrane, damage of mucin layer around PC, PC-DNA damage etc. The polysaccharide (GRPP) fraction and antioxidant extract (GRAOX) of ginger was examined for their ability to inhibit H+ K+ ATPase. Results indicated that the inhibition of H+ K+ ATPase activity which causes acidity in the lumen of the stomach, also exhibited better H+K+ ATPase inhibition (PPI) at the IC50 of 27.2 ?g (GRPP) and 16.5 ?g GAE (AOX) respectively than the known antiulcer proton pump blocker Lansoprazole (19.3 ?g). Further the antioxidant activity in antioxidant extract (GRAOX) by various assay systems was examined such as Reducing power, Free radical scavenging (FRS), DNA and cytoprotection systems etc. GRAOX exhibited concentration dependent reducing power ability at 5-25 ?g equivalent of phenol. FRS activity with IC50 of 6.8 ?g equivalent of phenol etc. At 0.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: April 17, 2012
    Assignee: Council of Scientific and Industrial Research
    Inventors: Shylaja Mallaiah Dharmesh, Mugur Nanjudaiah Siddaraju
  • Publication number: 20090131364
    Abstract: Ulcer is a serious oxidative stress induced disease with complex pathologic events including upregulation of H+K+ ATPase of parietal cell (PC) membrane, damage of mucin layer around PC, PC-DNA damage etc. The polysaccharide (GRPP) fraction and antioxidant extract (GRAOX) of ginger was examined for their ability to inhibit H+ K+ ATPase. Results indicated that the inhibition of H+ K+ ATPase activity which causes acidity in the lumen of the stomach, also exhibited better H+K+ ATPase inhibition (PPI) at the IC50 of 27.2 ?g (GRPP) and 16.5 ?g GAE (AOX) respectively than the known antiulcer proton pump blocker Lansoprazole (19.3 ?g). Further the antioxidant activity in antioxidant extract (GRAOX) by various assay systems was examined such as Reducing power, Free radical scavenging (FRS), DNA and cytoprotection systems etc. GRAOX exhibited concentration dependent reducing power ability at 5-25 g equivalent of phenol. FRS activity with IC50 of 6.8 ?g equivalent of phenol etc. At 0.
    Type: Application
    Filed: March 30, 2007
    Publication date: May 21, 2009
    Inventors: Shylaja Mallaiah Dharmesh, Mugur Nanjudaiah Siddaraju